Presentations

«Go Back

BT200 increases von Willebrand factor (VWF), Factor VIII and platelet counts in patients with von Willebrand disease (VWD) type IIb


Contact

© 2022 Guardian Therapeutics. All rights reserved.

Headquarters
Guardian Therapeutics
101 Hartwell Avenue
Suite 2
Lexington, MA 02421
+1 (781) 918-6580

General Inquiries:
info@guardian-rx.com

Business Development Inquiries: businessdevelopment@guardian-rx.com